These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer. Berry E, Matthews KS, Singh DK, Buttin BM, Lurain JR, Alvarez RD, Schink J. Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457 [Abstract] [Full Text] [Related]
4. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer. Lan C, Li Y, Liu J. Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124 [Abstract] [Full Text] [Related]
5. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer. Barlin JN, Dao F, Bou Zgheib N, Ferguson SE, Sabbatini PJ, Hensley ML, Bell-McGuinn KM, Konner J, Tew WP, Aghajanian C, Chi DS. Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622 [Abstract] [Full Text] [Related]
6. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy. Esselen KM, Rodriguez N, Growdon W, Krasner C, Horowitz NS, Campos S. Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193 [Abstract] [Full Text] [Related]
7. Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma. Arts HJ, Willemse PH, Tinga DJ, de Vries EG, van der Zee AG. Gynecol Oncol; 1998 Apr; 69(1):32-5. PubMed ID: 9570995 [Abstract] [Full Text] [Related]
10. Safety and outcome of patients treated with a modified outpatient intraperitoneal regimen for epithelial ovarian, primary peritoneal or fallopian tube cancer. Battelli C, Campo M, Buss MK, Awtrey CS, Konstantinopoulos PA. Chemotherapy; 2013 Apr; 59(4):251-9. PubMed ID: 24457572 [Abstract] [Full Text] [Related]
11. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602. Onda T, Matsumoto K, Shibata T, Sato A, Fukuda H, Konishi I, Kamura T, Yoshikawa H, Japan Clinical Oncology Group. Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715 [Abstract] [Full Text] [Related]
17. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer. Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987 [Abstract] [Full Text] [Related]
18. It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters. Henretta MS, Anderson CL, Angle JF, Duska LR. Gynecol Oncol; 2011 Nov; 123(2):342-5. PubMed ID: 21840583 [Abstract] [Full Text] [Related]